Regional perspectives on the coordination and delivery of paediatric end-of-life care in the UK: a qualitative study.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
16 Aug 2023
Historique:
received: 27 02 2023
accepted: 01 08 2023
medline: 18 8 2023
pubmed: 17 8 2023
entrez: 16 8 2023
Statut: epublish

Résumé

Provision of and access to paediatric end-of-life care is inequitable, but previous research on this area has focused on perspectives of health professionals in specific settings or children with specific conditions. This qualitative study aimed to explore regional perspectives of the successes, and challenges to the equitable coordination and delivery of end-of-life care for children in the UK. The study provides an overarching perspective on the challenges of delivering and coordinating end-of-life care for children in the UK, and the impact of these on health professionals and organisations. Previous research has not highlighted the successes in the sector, such as the formal and informal coordination of care between different services and sectors. Semi-structured interviews with Chairs of the regional Palliative Care Networks across the UK. Chairs or co-Chairs (n = 19) of 15/16 Networks were interviewed between October-December 2021. Data were analysed using thematic analysis. Three main themes were identified: one standalone theme ("Communication during end-of-life care"); and two overarching themes ("Getting end-of-life services and staff in the right place", with two themes: "Access to, and staffing of end-of-life care" and "Inconsistent and insufficient funding for end-of-life care services"; and "Linking up healthcare provision", with three sub-themes: "Coordination successes", "Role of the networks", and "Coordination challenges"). Good end-of-life care was facilitated through collaborative and network approaches to service provision, and effective communication with families. The implementation of 24/7 advice lines and the formalisation of joint-working arrangements were highlighted as a way to address the current challenges in the specialism. Findings demonstrate how informal and formal relationships between organisations and individuals, enabled early communication with families, and collaborative working with specialist services. Formalising these could increase knowledge and awareness of end of life care, improve staff confidence, and overall improve professionals' experiences of delivering care, and families' experiences of receiving it. There are considerable positives that come from collaborative working between different organisations and sectors, and care could be improved if these approaches are funded and formalised. There needs to be consistent funding for paediatric palliative care and there is a clear need for education and training to improve staff knowledge and confidence.

Sections du résumé

BACKGROUND BACKGROUND
Provision of and access to paediatric end-of-life care is inequitable, but previous research on this area has focused on perspectives of health professionals in specific settings or children with specific conditions. This qualitative study aimed to explore regional perspectives of the successes, and challenges to the equitable coordination and delivery of end-of-life care for children in the UK. The study provides an overarching perspective on the challenges of delivering and coordinating end-of-life care for children in the UK, and the impact of these on health professionals and organisations. Previous research has not highlighted the successes in the sector, such as the formal and informal coordination of care between different services and sectors.
METHODS METHODS
Semi-structured interviews with Chairs of the regional Palliative Care Networks across the UK. Chairs or co-Chairs (n = 19) of 15/16 Networks were interviewed between October-December 2021. Data were analysed using thematic analysis.
RESULTS RESULTS
Three main themes were identified: one standalone theme ("Communication during end-of-life care"); and two overarching themes ("Getting end-of-life services and staff in the right place", with two themes: "Access to, and staffing of end-of-life care" and "Inconsistent and insufficient funding for end-of-life care services"; and "Linking up healthcare provision", with three sub-themes: "Coordination successes", "Role of the networks", and "Coordination challenges"). Good end-of-life care was facilitated through collaborative and network approaches to service provision, and effective communication with families. The implementation of 24/7 advice lines and the formalisation of joint-working arrangements were highlighted as a way to address the current challenges in the specialism.
CONCLUSIONS CONCLUSIONS
Findings demonstrate how informal and formal relationships between organisations and individuals, enabled early communication with families, and collaborative working with specialist services. Formalising these could increase knowledge and awareness of end of life care, improve staff confidence, and overall improve professionals' experiences of delivering care, and families' experiences of receiving it. There are considerable positives that come from collaborative working between different organisations and sectors, and care could be improved if these approaches are funded and formalised. There needs to be consistent funding for paediatric palliative care and there is a clear need for education and training to improve staff knowledge and confidence.

Identifiants

pubmed: 37587514
doi: 10.1186/s12904-023-01238-w
pii: 10.1186/s12904-023-01238-w
pmc: PMC10428585
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Am J Hosp Palliat Care. 2013 Mar;30(2):172-7
pubmed: 22531150
J Nurs Law. 2005 Winter;10(4):216-24
pubmed: 17111534
Child Care Health Dev. 2007 Sep;33(5):619-24
pubmed: 17725785
J Palliat Med. 2014 Jan;17(1):80-4
pubmed: 24410421
Palliat Med. 2009 Sep;23(6):526-36
pubmed: 19351793
BMJ Open. 2019 May 9;9(5):e028548
pubmed: 31072863
BMC Palliat Care. 2019 Jul 11;18(1):55
pubmed: 31296209
BMJ. 2022 May 11;377:o1146
pubmed: 35545252
J Pain Symptom Manage. 2020 Feb;59(2):339-364.e10
pubmed: 31404638
Pediatr Blood Cancer. 2022 Jun;69(6):e29621
pubmed: 35293690
Arch Dis Child. 2022 Jan;107(1):59-64
pubmed: 33980510
BMJ Support Palliat Care. 2019 Dec;9(4):439-450
pubmed: 31324615
BMJ Support Palliat Care. 2022 Jun 16;:
pubmed: 35710708
Am J Hosp Palliat Care. 2020 Jun;37(6):424-432
pubmed: 31884806
Arch Dis Child. 2012 Apr;97(4):381-4
pubmed: 22039176
NIHR Open Res. 2022 May 13;2:37
pubmed: 35935675
Arch Dis Child. 2021 Jun;106(6):570-576
pubmed: 33199300
BMC Palliat Care. 2021 Jan 22;20(1):20
pubmed: 33482795
BMC Palliat Care. 2013 Apr 25;12(1):18
pubmed: 23617814
BMC Palliat Care. 2015 Nov 05;14:57
pubmed: 26542477
Healthcare (Basel). 2021 Nov 23;9(12):
pubmed: 34946341
Arch Dis Child. 2017 Oct;102(10):923-929
pubmed: 28377450
Palliat Med. 2021 Mar;35(3):503-528
pubmed: 33372582
Am J Hosp Palliat Care. 2021 Nov;38(11):1378-1390
pubmed: 33423532
J Am Geriatr Soc. 2008 Oct;56(10):1953-8
pubmed: 18771455
Int J Palliat Nurs. 2013 May;19(5):251-6
pubmed: 23971309
J Palliat Med. 2016 Mar;19(3):326-32
pubmed: 26862782
J Palliat Med. 2014 Mar;17(3):288-95
pubmed: 24528125
Int J Palliat Nurs. 2012 Apr;18(4):197-201
pubmed: 22584391
Palliat Med. 2021 Oct;35(9):1641-1651
pubmed: 33323043

Auteurs

Andrew Papworth (A)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK.
Department of Health Sciences, University of York, York, YO10 5DD, UK.

Julia Hackett (J)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK. julia.hackett@york.ac.uk.
Department of Health Sciences, University of York, York, YO10 5DD, UK. julia.hackett@york.ac.uk.

Bryony Beresford (B)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK.
Social Policy Research Unit, University of York, York, YO10 5DD, UK.

Fliss Murtagh (F)

Hull York Medical School, University of Hull, Hull, HU6 7RX, UK.

Helen Weatherly (H)

Centre for Health Economics, University of York, York, YO10 5DD, UK.

Sebastian Hinde (S)

Centre for Health Economics, University of York, York, YO10 5DD, UK.

Andre Bedendo (A)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK.
Department of Health Sciences, University of York, York, YO10 5DD, UK.

Gabriella Walker (G)

Parent and Public Involvement member, York, UK.

Jane Noyes (J)

School of Medical and Health Sciences, Bangor University, Bangor, LL57 2EF, UK.

Sam Oddie (S)

Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.

Chakrapani Vasudevan (C)

Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.

Richard G Feltbower (RG)

Leeds Institute for Data Analytics, School of Medicine, University of Leeds, Leeds, LS2 9NL, UK.

Bob Phillips (B)

Centre for Reviews and Dissemination, University of York, York, YO10 5DD, UK.

Richard Hain (R)

All-Wales Paediatric Palliative Care Network, Cardiff and Vale University Health Board, Cardiff, CF14 4XW, UK.
College of Human and Health Sciences, Swansea University, Swansea, SA2 8PP, UK.

Gayathri Subramanian (G)

Manchester University NHS Foundation Trust, Manchester, M13 9WL, UK.

Andrew Haynes (A)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK.
Department of Health Sciences, University of York, York, YO10 5DD, UK.

Lorna K Fraser (LK)

Department of Health Sciences, Martin House Research Centre, University of York, Heslington, YO10 5DD, York, UK.
Department of Health Sciences, University of York, York, YO10 5DD, UK.
Cicely Saunders Institute, Kings College London, Bessemer Road, London, SE5 9PJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH